Clinical Trial Update: Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico [Phase 4]

View source ↗

Summary

A Phase 4 trial in Mexico compares darunavir/cobicistat plus lamivudine versus darunavir/cobicistat plus tenofovir/emtricitabine in virologically suppressed HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lamivudine (lamivudine)
• darunavir/cobicistat (darunavir/cobicistat)
• tenofovir disoproxil fumarate/emtricitabine (tenofovir disoproxil fumarate/emtricitabine)

Snippet

Sponsor: José Antonio Mata Marín | Conditions: HIV Infection | Phase 4 | Status: RECRUITING